跳至主要内容
临床试验/NCT01455610
NCT01455610Unknown不适用

Preoperative Evaluation of Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study

Meng Su Zeng6 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
140
试验地点
6

研究概览

简要总结

The purpose of this multicenter and double-blind clinical trial is to prospectively assess the sensitivity, specificity, negative predictive value, positive predictive value, and accuracy in respectability of pancreatic head cancer with contrasted-enhanced MDCT and its various post processing techniques, taking operational and pathological records as the gold standard.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with (or suspected) pancreatic head cancer
  • Being examined by contrasted-enhanced MDCT
  • Receiving surgical treatment (including palliative surgery) in all research centers

排除标准

  • Patients having (or suspected) pregnancy or breast-feeding
  • Patients having allergic reactions to iodinated contrast agents or Hypersensitivity reactions to allergens(including drugs)
  • Patients receiving ERCP before contrasted-enhanced MDCT examination
  • Patients without surgery because of a high degree of surgical risk

研究者

发起方
Meng Su Zeng
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Meng Su Zeng

Mengsu Zeng, MD & Ph.D,Chairman & Professor,Department of Radiology

Shanghai Zhongshan Hospital

研究点 (6)

Loading locations...

相似试验